Lumbar Decompression with Liposomal Bupivacaine Study
This study is looking at whether using liposomal bupivacaine (a long-acting local anesthetic) during surgery for lumbar spinal stenosis (a narrowing of the spinal canal in the lower back) can help patients recover faster. Researchers will compare patients who receive liposomal bupivacaine to those who receive a standard local anesthetic during their surgery. The main goal is to see if liposomal bupivacaine can shorten your hospital stay. You may be able to join if you are an adult (18 or older) having surgery for lumbar spinal stenosis and meet other health requirements. The current status of this study is unclear, but it plans to enroll 100 participants.
- Study design
- This interventional study plans to enroll 100 participants. It compares the effects of liposomal bupivacaine to a standard local anesthetic during surgery.
- What's involved
- You would receive an injection of either liposomal bupivacaine or a standard local anesthetic during your surgical procedure.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your hospital stay will be assessed from admission until discharge, up to 2 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Overall length of hospital stay from hospital admission to hospital dischargeFrom date of hospital admission until date of hospital discharge, assessed up to 2 weeks.
Length of stay will be measured in hours